1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. NEUROGENE INC
Neurogene Inc XNAS: NGNE
18.31 -0.68 (-3.58%)
78,528
XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Neurogene Inc - NGNE - stock price prediction, stock price target, analyst ratings from 6 analysts

Neurogene Inc has a share price target of US$ 59 and profit growth estimate of -21.2% for Unknown Year, based on top 6 analyst calls.